Novel modified leucine and phenylalanine dipeptides modulate viability and attachment of cancer cells
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61389030%3A_____%2F20%3A00523649" target="_blank" >RIV/61389030:_____/20:00523649 - isvavai.cz</a>
Alternative codes found
RIV/61989592:15310/20:73604618 RIV/00216275:25310/20:39916447 RIV/00216208:11310/20:10414362
Result on the web
<a href="http://doi.org/10.1016/j.ejmech.2020.112036" target="_blank" >http://doi.org/10.1016/j.ejmech.2020.112036</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ejmech.2020.112036" target="_blank" >10.1016/j.ejmech.2020.112036</a>
Alternative languages
Result language
angličtina
Original language name
Novel modified leucine and phenylalanine dipeptides modulate viability and attachment of cancer cells
Original language description
Here, we describe the synthesis and biological characterization of 32 novel phenylalanine and leucine dipeptides modified on both the N and C termini by salicylic acid and aromatic or alicyclic amines, respectively. All compounds displayed antiproliferative activity in the tested cancer cell lines and eight of the compounds exhibited single digit micromolar GI50 values. Treated cells rapidly detached from surface of tissue culture dishes and we found that focal adhesion kinase (FAK), p130CAS and paxillin, which are important regulators of cell adhesion, were dephosphorylated at Y397, Y410 and Y118, respectively. The most potent compound reduced proliferation in the HCT-116 cell line in a dose-dependent manner, as shown by a decrease in 5-bromo-2′-deoxyuridine incorporation into DNA. Furthermore, this compound increased the levels of several apoptotic markers, including activated caspases, and increased site-specific poly-(ADP-ribose)polymerase (PARP) cleavage.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30107 - Medicinal chemistry
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Journal of Medicinal Chemistry
ISSN
0223-5234
e-ISSN
—
Volume of the periodical
188
Issue of the periodical within the volume
FEB 15
Country of publishing house
FR - FRANCE
Number of pages
13
Pages from-to
112036
UT code for WoS article
000515428100039
EID of the result in the Scopus database
2-s2.0-85077649747